This Dividend Growth Stock could Pop 239% (Again!) on Jay Powell’s “Revenge Tour”
The future looks bright.
Read Moreby Brett Owens, Contrarian Outlook | Nov 21, 2024
The future looks bright.
Read Moreby Keith Speights, The Motley Fool | Nov 21, 2024
One stands out as the best choice for income and value investors (and should have solid growth prospects).
Read Moreby Dr. David Eifrig, DailyWealth.com | Nov 21, 2024
Once you learn how to sell options on your own, you’ll unlock an income secret that’s much easier than you might think.
Read Moreby Brett Eversole, DailyWealth.com | Nov 20, 2024
According to history, the good times are just beginning.
Read Moreby Brett Owens, Contrarian Outlook | Nov 20, 2024
Both are growing their dividends, and both have been unfairly left behind in this year’s rally.
Read Moreby Leo Sun, The Motley Fool | Nov 20, 2024
Saylor expects it to soar even higher.
Read Moreby Tara Young, Trades Of The Day | Nov 20, 2024
With the bulls gaining control, our target potential upside is 14%-25% in the next 3-6 months.
Read Moreby TheFly.com | Nov 20, 2024
Here are today’s upgrades and downgrades: JPMorgan, Chewy, SolarEdge, AstraZeneca, Lemonade, Energizer and more.
Read Moreby Brad Thomas, Wide Moat Research | Nov 19, 2024
From an investment perspective, it’s been a good stock to own, rising some 3,000% over the last 20 years. And its P/E and P/B ratios are running on the low end of their 10-year ranges (so Buffett saw the deal and went for it).
Read Moreby George Budwell, The Motley Fool | Nov 19, 2024
They keep drawing my investment dollars in this market.
Read Moreby Sean Michael Cummings, Daily Wealth | Nov 19, 2024
Consider adding exposure to your portfolio today.
Read Moreby Trades of the Day Research Team | Nov 19, 2024
On analyzing the company’s stock charts, there seem to be multiple bullish indications…
Read More